A bill to amend the Controlled Substances Act to schedule MGM-15 and MGM-16 as schedule I controlled substances, and to amend the controlled Substances Act to schedule synthetic 7-hydroxymitragynine, and Mitragynine Pseudoindoxyl, as a Schedule I above a specific threshold under the controlled substance act, and to expand enforcement actions against drug manufacturers and distributors of emerging synthetic opioids, commonly known as gas station heroin.
Bill Summary
Bans two specific substances, MGM-15 and MGM-16, and two related compounds, by adding them to the list of controlled substances, and increases enforcement against makers and sellers of certain synthetic opioids. Requires stricter control of these substances above a certain amount.
Read Full SummarySponsored By
Support By Party
View details →Bill Journey
- TBD
The full chamber debates the bill, may amend it, and votes on whether to pass it.
- TBD
If passed by the first chamber, the other chamber considers, may amend, and votes on the bill.
- TBD
If passed by both chambers, the bill goes to the President to sign into law or veto.
Why It Matters
This bill affects manufacturers and distributors of synthetic opioids, who will face increased enforcement and penalties, and individuals who use these substances, who will have reduced access to them. It also impacts businesses, such as gas stations, that may sell these substances, by increasing their liability and potential for penalties.